MCCRX
Price
$18.57
Change
-$0.08 (-0.43%)
Updated
Jul 31 closing price
Net Assets
592.58M
VSMAX
Price
$141.38
Change
-$0.34 (-0.24%)
Updated
Jul 31 closing price
Net Assets
188.57B
Interact to see
Advertisement

MCCRX vs VSMAX

MCCRX vs VSMAX Comparison Chart in %
View a ticker or compare two or three
VS
MCCRX vs. VSMAX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MCCRX is a Buy and VSMAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSMAX has more cash in the bank: 189B vs. MCCRX (593M). VSMAX pays higher dividends than MCCRX: VSMAX (1.21) vs MCCRX (0.03). MCCRX was incepted earlier than VSMAX: MCCRX (12 years) vs VSMAX (26 years). MCCRX (1.35) is less costly to investors than VSMAX (0.05). MCCRX is a more actively managed with annual turnover of: 40.00 vs. VSMAX (17.00). MCCRX has a lower initial minimum investment than VSMAX: MCCRX (0) vs VSMAX (3000). VSMAX annual gain was more profitable for investors over the last year : 22.58 vs. MCCRX (13.27). VSMAX return over 5 years is better than : 35.11 vs. MCCRX (3.22).
MCCRXVSMAXMCCRX / VSMAX
Total Expense Ratio1.350.052,700%
Annual Report Gross Expense Ratio1.350.052,700%
Fund Existence12 years26 years-
Gain YTD16.49914.588113%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets593M189B0%
Annual Yield % from dividends0.031.213%
Returns for 1 year13.2722.5859%
Returns for 3 years15.3243.4235%
Returns for 5 years3.2235.119%
Returns for 10 years41.28155.9626%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BQLCX23.420.17
+0.73%
Bright Rock Quality Large Cap Instl
GSPQX20.020.12
+0.60%
Goldman Sachs US Eq Div and Premium C
GSIYX24.29N/A
N/A
Goldman Sachs GQG Ptnrs Intl Opps R6
CCWIX21.73-0.15
-0.69%
Baird Chautauqua International Gr Instl
RYOAX66.89-1.55
-2.26%
Rydex Biotechnology H